Advertisement

Inflammation

, Volume 32, Issue 2, pp 83–88 | Cite as

Inhalation of Carbon Monoxide Ameliorates Collagen-induced Arthritis in Mice and Regulates the Articular Expression of IL-1β and MCP-1

  • Tomohisa Takagi
  • Yuji Naito
  • Mamoru Inoue
  • Satomi Akagiri
  • Katsura Mizushima
  • Osamu Handa
  • Satoshi Kokura
  • Hiroshi Ichikawa
  • Toshikazu Yoshikawa
Article

Abstract

Carbon monoxide (CO), long considered a toxic gas, has recently been shown to mediate anti-inflammatory effects in various animal models. The aim of this study was to investigate whether the inhalation of CO ameliorated collagen-induced arthritis (CIA) in mice. CIA was induced in female DBA/1 mice by the injection of an anti-type II collagen antibody and lipopolysaccharide. The CO treatment group was exposed to CO gas at a concentration of 200 ppm in a closed cage starting on the day of the injection with an anti-type II collagen antibody and throughout the remaining study period. The clinical arthritis scores was examined daily for swelling of the paws as a sign of arthritis. For histopathology, the sections of the hind legs were evaluated by hematoxylin-eosin staining. Moreover, we evaluated the expression of interleukin (IL)-1β and monocyte chemoattractant protein-1 (MCP-1) mRNA in the hind paws. Both clinical arthritis scores as well as histological findings of joint inflammation were significantly reduced in mice treated with CO gas inhalation compared to untreated mice. Further, CO significantly inhibited the increased expression of IL-1β and MCP-1 mRNA in paws at day 3 after the induction of arthritis. In conclusion, the inhalation of CO protected mice from the synovial inflammation of CIA. Based on these data, the beneficial effects of CO in murine RA model may be attributed to its anti-inflammatory properties.

KEY WORDS

carbon monoxide collagen-induced arthritis heme oxygenase 

Notes

Acknowledgments

This work was supported by a Grant-in-Aid for scientific research (Grant no. 18590694) from the Ministry of Health, Labour and Welfare of Japan.

References

  1. 1.
    Wey, C. M., and J. J. Goronzy. 1997. Pathogenesis of rheumatoid arthritis. Med. Clin. North Am. 81(1):29–55.CrossRefGoogle Scholar
  2. 2.
    Firestein, G. S. 2003. Evolving concepts of rheumatoid arthritis. Nature. 423(6937):356–361.PubMedCrossRefGoogle Scholar
  3. 3.
    Choy, E. H., and G. S. Panayi. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344(12):907–916.PubMedCrossRefGoogle Scholar
  4. 4.
    Koch, A. E., S. L. Kunkel, L. A. Harlow, B. Johnson, H. L. Evanoff, G. K. Haines, et al. 1992. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J. Clin. Invest. 90(3):772–779.PubMedCrossRefGoogle Scholar
  5. 5.
    Koch, A. E., S. L. Kunkel, L. A. Harlow, D. D. Mazarakis, G. K. Haines, M. D. Burdick, et al. 1994. Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J. Clin. Invest. 93(3):921–928.PubMedCrossRefGoogle Scholar
  6. 6.
    Feldmann, M., M. J. Elliott, J. N. Woody, and R. N. Maini. 1997. Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis. Adv. Immunol. 64:283–350.PubMedCrossRefGoogle Scholar
  7. 7.
    Jin, Y., and A. M. Choi. 2005. Cytoprotection of heme oxygenase-1/carbon monoxide in lung injury. Proc. Am. Thorac. Soc. 2(3):232–235.PubMedCrossRefGoogle Scholar
  8. 8.
    Kim, H. P., S. W. Ryter, and A. M. Choi. 2006. CO as a cellular signaling molecule. Annu. Rev. Pharmacol. Toxicol. 46:411–449.PubMedCrossRefGoogle Scholar
  9. 9.
    Otterbein, L. E., L. L. Mantell, and A. M. Choi. 1999. Carbon monoxide provides protection against hyperoxic lung injury. Am. J. Physiol. 276(4 Pt 1):L688–L694.PubMedGoogle Scholar
  10. 10.
    Kaizu, T., A. Nakao, A. Tsung, H. Toyokawa, R. Sahai, D. A. Geller, et al. 2005. Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation. Surgery 138(2):229–235.PubMedCrossRefGoogle Scholar
  11. 11.
    Nakao, A., K. Kimizuka, D. B. Stolz, J. S. Neto, T. Kaizu, A. M. Choi, et al. 2003. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am. J. Pathol. 163(4):1587–1598.PubMedGoogle Scholar
  12. 12.
    Neto, J. S., A. Nakao, K. Kimizuka, A. J. Romanosky, D. B. Stolz, T. Uchiyama, et al. 2004. Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am. J. Physiol. Renal. Physiol. 287(5):F979–F989.PubMedCrossRefGoogle Scholar
  13. 13.
    Otterbein, L. E., F. H. Bach, J. Alam, M. Soares, H. Tao Lu, M. Wysk, et al. 2000. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6(4):422–428.PubMedCrossRefGoogle Scholar
  14. 14.
    Hegazi, R. A., K. N. Rao, A. Mayle, A. R. Sepulveda, L. E. Otterbein, and S. E. Plevy. 2005. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J. Exp. Med. 202(12):1703–1713.PubMedCrossRefGoogle Scholar
  15. 15.
    Tsui, T. Y., A. Obed, Y. T. Siu, S. F. Yet, L. Prantl, H. J. Schlitt, et al. 2007. Carbon monoxide inhalation rescues mice from fulminant hepatitis through improving hepatic energy metabolism. Shock 27(2):165–171.PubMedCrossRefGoogle Scholar
  16. 16.
    Maines, M. D. 1997. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37:517–554.PubMedCrossRefGoogle Scholar
  17. 17.
    Sassa, S. 2006. Biological implications of heme metabolism. J. Clin. Biochem. Nutr. 38:138–155.CrossRefGoogle Scholar
  18. 18.
    Naito, Y., T. Takagi, and T. Yoshikawa. 2004. Heme oxygenase-1: a new therapeutic target for inflammatory bowel disease. Aliment Pharmacol. Ther. 20(Suppl 1):177–184.PubMedCrossRefGoogle Scholar
  19. 19.
    Kobayashi, H., M. Takeno, T. Saito, Y. Takeda, Y. Kirino, K. Noyori, et al. 2006. Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum. 54(4):1132–1142.PubMedCrossRefGoogle Scholar
  20. 20.
    Terato, K., D. S. Harper, M. M. Griffiths, D. L. Hasty, X. J. Ye, M. A. Cremer, et al. 1995. Collagen-induced arthritis in mice: synergistic effect of E. coli lipopolysaccharide bypasses epitope specificity in the induction of arthritis with monoclonal antibodies to type II collagen. Autoimmunity 22(3):137–147.PubMedCrossRefGoogle Scholar
  21. 21.
    Terato, K., K. A. Hasty, R. A. Reife, M. A. Cremer, A. H. Kang, and J. M. Stuart. 1992. Induction of arthritis with monoclonal antibodies to collagen. J. Immunol. 148(7):2103–2108.PubMedGoogle Scholar
  22. 22.
    Kagari, T., H. Doi, and T. Shimozato. 2002. The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J. Immunol. 169(3):1459–1466.PubMedGoogle Scholar
  23. 23.
    Nakao, A., H. Toyokawa, M. Abe, T. Kiyomoto, K. Nakahira, A. M. Choi, et al. 2006. Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive T-cell responses. Transplantation 81(2):220–230.PubMedCrossRefGoogle Scholar
  24. 24.
    Favory, R., S. Lancel, S. Tissier, D. Mathieu, B. Decoster, and R. Neviere. 2006. Myocardial dysfunction and potential cardiac hypoxia in rats induced by carbon monoxide inhalation. Am. J. Respir. Crit. Care Med. 174(3):320–325.PubMedCrossRefGoogle Scholar
  25. 25.
    Gautier, M., D. Antier, P. Bonnet, J. L. Le Net, G. Hanton, and V. Eder. 2007. Continuous inhalation of carbon monoxide induces right ventricle ischemia and dysfunction in rats with hypoxic pulmonary hypertension. Am. J. Physiol. Heart Circ. Physiol. 293(2):H1046–H1052.PubMedCrossRefGoogle Scholar
  26. 26.
    Thornton, S., L. E. Duwel, G. P. Boivin, Y. Ma, and R. Hirsch. 1999. Association of the course of collagen-induced arthritis with distinct patterns of cytokine and chemokine messenger RNA expression. Arthritis Rheum. 42(6):1109–1118.PubMedCrossRefGoogle Scholar
  27. 27.
    Marinova-Mutafchieva, L., R. O. Williams, L. J. Mason, C. Mauri, M. Feldmann, and R. N. Maini. 1997. Dynamics of proinflammatory cytokine expression in the joints of mice with collagen-induced arthritis (CIA). Clin. Exp. Immunol. 107(3):507–512.PubMedCrossRefGoogle Scholar
  28. 28.
    Gomez-Reino, J. J., J. L. Pablos, P. E. Carreira, B. Santiago, L. Serrano, J. L. Vicario, et al. 1999. Association of rheumatoid arthritis with a functional chemokine receptor, CCR5. Arthritis Rheum. 42(5):989–992.PubMedCrossRefGoogle Scholar
  29. 29.
    Taub, D. D., K. Conlon, A. R. Lloyd, J. J. Oppenheim, and D. J. Kelvin. 1993. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1 alpha and MIP-1 beta. Science 260(5106):355–358.PubMedCrossRefGoogle Scholar
  30. 30.
    Cai, J. P., S. Hudson, M. W. Ye, and Y. H. Chin. 1996. The intracellular signaling pathways involved in MCP-1-stimulated T cell migration across microvascular endothelium. Cell Immunol. 167(2):269–275.PubMedCrossRefGoogle Scholar
  31. 31.
    Borzi, R. M., I. Mazzetti, L. Cattini, M. Uguccioni, M. Baggiolini, and A. Facchini. 2000. Human chondrocytes express functional chemokine receptors and release matrix-degrading enzymes in response to C-X-C and C-C chemokines. Arthritis Rheum. 43(8):1734–1741.PubMedCrossRefGoogle Scholar
  32. 32.
    Kunkel, S. L., N. Lukacs, T. Kasama, and R. M. Strieter. 1996. The role of chemokines in inflammatory joint disease. J. Leukoc. Biol. 59(1):6–12.PubMedGoogle Scholar
  33. 33.
    Ogata, H., M. Takeya, T. Yoshimura, K. Takagi, and K. Takahashi. 1997. The role of monocyte chemoattractant protein-1 (MCP-1) in the pathogenesis of collagen-induced arthritis in rats. J. Pathol. 182(1):106–114.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Tomohisa Takagi
    • 1
  • Yuji Naito
    • 1
  • Mamoru Inoue
    • 2
  • Satomi Akagiri
    • 3
  • Katsura Mizushima
    • 1
  • Osamu Handa
    • 1
  • Satoshi Kokura
    • 1
  • Hiroshi Ichikawa
    • 1
  • Toshikazu Yoshikawa
    • 1
    • 3
  1. 1.Department of Molecular Gastroenterology and Hepatology, Graduate School of Medical SienceKyoto Prefectural University of MedicineKyotoJapan
  2. 2.Department of Internal MedicineKyoto Second Red Cross HospitalKyotoJapan
  3. 3.Biomedical Safety Science, Graduate School of Medical ScienceKyoto Prefectural University of MedicineKyotoJapan

Personalised recommendations